This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Iwamura, M. Articles by Abrahamsson, P.-A. Search for Related Content PubMed PubMed Citation Articles by Iwamura, M. Articles by Abrahamsson, P.-A.

Immunohistochemical Localization of Parathyroid Hormone-related Protein in Human Prostate Cancer¹

Departments of Urology [M. I., G. W., C. M. B., A. T. K. C., P-A. A.] and Surgical Pathology [P. A. di S.], University of Rochester School of Medicine, Rochester, New York 14642-8656; Department of Medicine, University of California, San Diego, and the San Diego Veterans Administration Medical Center, La Jolla, California 92161 [L. J. D.]

Parathyroid hormone-related protein (PTHrP) is produced by a variety of malignant tumors and has been implicated as a major cause of humoral hypercalcemia of malignancy. Expression of PTHrP in prostate cancer tissue was studied immunohistochemically using 33 radical prostatectomy specimens from patients with clinically localized carcinoma of the prostate. None of these patients demonstrated hypercalcemia prior to the surgery. Acetone-methyl benzoate-xylene-processed, paraffin-embedded tissues were stained with a validated mouse monoclonal antibody to an amino acid fragment, PTHrP(109–141), using the streptavidin-peroxidase enzyme conjugate method. All cases (33 of 33; 100%) studied demonstrated some degree of immunoreactivity throughout the cytoplasm of the tumor cells, but immunostaining was absent from inflammatory and stromal cells. The intensity of the staining appeared to directly correlate with increasing tumor grade. The widespread immunohistochemical localization of PTHrP in carcinoma of the prostate suggests that PTHrP may play some local role in the growth of transformed cells in the prostate. Furthermore, overexpression of PTHrP may be a possible marker to evaluate the malignant potential of carcinoma of the prostate.

¹ Supported by National Cancer Institute Grants CA47373 and CA49474, NIH Grant AR15888, and the Department of Veterans Affairs.

² To whom requests for reprints should be addressed, at the Department of Urology, Box 656, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642-8656.

Received 1/14/93. Accepted 3/ 5/93.

This article has been cited by other articles:

				F. C Perez-Martinez, V. Alonso, J. L Sarasa, S.-G. Nam-Cha, R. Vela-Navarrete, F. Manzarbeitia, F. J Calahorra, and P. Esbrit Immunohistochemical analysis of low-grade and high-grade prostate carcinoma: relative changes of parathyroid hormone-related protein and its parathyroid hormone 1 receptor, osteoprotegerin and receptor activator of nuclear factor-kB ligand J. Clin. Pathol., March 1, 2007; 60(3): 290 - 284. [Abstract] [Full Text] [PDF]

				M. Zayzafoon, S. A. Abdulkadir, and J. M. McDonald Notch Signaling and ERK Activation Are Important for the Osteomimetic Properties of Prostate Cancer Bone Metastatic Cell Lines J. Biol. Chem., January 30, 2004; 279(5): 3662 - 3670. [Abstract] [Full Text] [PDF]

				M. J. Morris and H. I. Scher Clinical Approaches to Osseous Metastases in Prostate Cancer Oncologist, April 1, 2003; 8(2): 161 - 173. [Abstract] [Full Text] [PDF]

				J. L. Sanders, N. Chattopadhyay, O. Kifor, T. Yamaguchi, and E. M. Brown Ca2+-sensing receptor expression and PTHrP secretion in PC-3 human prostate cancer cells Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1267 - E1274. [Abstract] [Full Text] [PDF]

				R. M. L. Murray, V. Grill, N. Crinis, P. W. M. Ho, J. Davison, and P. Pitt Hypocalcemic and Normocalcemic Hyperparathyroidism in Patients with Advanced Prostatic Cancer J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4133 - 4138. [Abstract] [Full Text] [PDF]

				K. M. Dougherty, E. A. G. Blomme, A. J. Koh, J. E. Henderson, K. J. Pienta, T. J. Rosol, and L. K. McCauley Parathyroid Hormone-related Protein as a Growth Regulator of Prostate Carcinoma Cancer Res., December 1, 1999; 59(23): 6015 - 6022. [Abstract] [Full Text] [PDF]

				T. Chen, R. W. Cho, P. J. S. Stork, and M. J. Weber Elevation of Cyclic Adenosine 3',5'-Monophosphate Potentiates Activation of Mitogen-activated Protein Kinase by Growth Factors in LNCaP Prostate Cancer Cells Cancer Res., January 1, 1999; 59(1): 213 - 218. [Abstract] [Full Text] [PDF]

				N. Buchs, J.-P. Bonjour, and R. Rizzoli Renal Tubular Reabsorption of Phosphate Is Positively Related to the Extent of Bone Metastatic Load in Patients with Prostate Cancer J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1535 - 1541. [Abstract] [Full Text]